Press Releases
Kaposi Sarcoma Market to Become Worth US$143.2 mn by 2024

US, 13 February 2018 -- Transparency Market Research states that the global Kaposi sarcoma market will exhibit a modest 2.2% CAGR over the period between 2016 and 2024, rising from a valuation of US$118.5 mn in 2015 to US$143.2 mn by 2024.

The global Kaposi sarcoma (KS) market is extremely consolidated with the top two players accounting for a combined share of almost 50% in 2015, finds Transparency Market Research (TMR). These companies are Johnson & Johnson and Merck & Co. Inc. Currently, the share of regional vendors, such as Sun Pharmaceutical Industries Limited, is noticeably low; however, in the coming years, their regional shares are anticipated to augment considerably, notes TMR. Owing to the large-scale patent expiry of numerous blockbuster drugs, particularly in the U.S., the market will expectedly witness several new entrants in the coming years. A significant number of these companies will be focusing on developing generics, unlocking a wealth of opportunities for leading drug makers.

Key strategies adopted by companies include partnerships and acquisitions; several market players are collaborating with prominent companies for developing new products with enhanced efficacy. The global Kaposi sarcoma market is anticipated to expand at a modest CAGR of 2.2% from 2016 to 2024. The market stood at US$118.5 mn in 2015 and is expected to reach US$143.2 mn by 2024.

Request to view Sample Report:

Chemotherapy Gaining Ground as Safe Treatment for Containing Kaposi Sarcoma

Geographically, the major regional markets for Kaposi sarcoma are Europe, North America, Asia Pacific, the Middle East & Africa (MEA), and Latin America. Of these, the Middle East and Africa market is projected to exhibit the most promising growth. The substantial demand for Kaposi sarcoma therapies is driven by its high prevalence and the increasing incidence of AIDS-induced Kaposi sarcoma in many parts of Eastern Africa.

Based on treatment method, the Kaposi sarcoma market is segmented into antiretroviral therapy, immunotherapy, and chemotherapy. Of these, the chemotherapy segment is expected to rise at a strong CAGR over the forecast period. The growing popularity of the treatment protocol is driven by its increased efficacy to contain cancer that has spread to multiple areas of the patient’s body. The treatment is also found to be effective in improving the quality of life in patients with classic or endemic Kaposi sarcoma.

Download Brochure of Report:

Increasing Incidence Epidemic Kaposi Sarcoma to Boost Uptake of Antiretroviral Therapies

Since Kaposi sarcoma is one of the most common AIDS-defining malignancies, the increasing number of people who are HIV-positive has increased the incidence of AIDS-associated Kaposi sarcoma. The increasing efficiency of highly active antiretroviral therapy (HAART) in the treatment of epidemic or AIDS-related KS has boosted the growth of the market. The popularity of antiretroviral therapy (ART) as the key treatment modality to improve overall health and survival rate among AIDS-related KS is expected to fuel the market.

The increasing rate of organ transplant procedures has increased the vulnerability of patients to Kaposi sarcoma cancer. This is another crucial factor driving the Kaposi sarcoma market in various regions. The rising incidence of Kaposi sarcoma associated herpesvirus (KSHV) infection among patients who have undergone organ transplants is expected to spur the demand for KS treatments.

Request For Discount On This Report:

However, the high cost of patented cancer drugs restrains patients especially in low- and middle-income countries to avail treatments, thereby hindering the growth of the market to an extent. On the other hand, the expected arrival of several generics and the soaring preference for chemo drugs among immunocompetent patients are expected to fuel the market over the forecast period. In addition, advancement in specific biomarkers in diagnosing KS is expected to open up lucrative market in the coming years.

The study presented here is based on a report by Transparency Market Research (TMR) titled “Kaposi Sarcoma Market (Treatment - Chemotherapy (Liposomal Anthracyclines and Alkaloids), Immunotherapy, and HAART); Distribution Channel - Hospitals, Cancer Research Institutes, Multispecialty Clinics, and Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”

# # #

Media Contacts:
Contact us:
Transparency Market Research
90 State Street,
Suite 700,
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453

Submitted by Sandy Researcher, Transparency Market Research on Tuesday, 13 February 2018 at 6:48 PM
Category: Health Care & Medical
Related News

Mechanical Ventilators Market is Anticipated to Reach US$ 2,937.3 Mn by 2026
Thursday, 17 Jan 2019

Global Gastrointestinal Endoscopy Devices Market Projected To Display At A CAGR Of 6.82% By 2023
Thursday, 17 Jan 2019

Global Biopharmaceutical CMO Market Booming With Lonza, Boehringer Ingelheium
Thursday, 17 Jan 2019

Global Biochip Market Scope, Overview, Trends and Demand By Manufacturers - Danaher Corp.
Thursday, 17 Jan 2019

Global HIV Therapeutics Market Should Reach $27.1 Billion By 2023 At A CAGR Of 4.3% By 2023
Thursday, 17 Jan 2019

Related Events

11th Annual ICJR Winter Hip and Knee Course, Vail 2019
Thursday, 17 Jan 2019

ICRS Summit, San Diego, 2019 - Bio/Orthopaedics in Sport Medicine
Thursday, 17 Jan 2019

9th Annual Orthopaedic Trauma and Fracture Care: Pushing the Envelope
Thursday, 17 Jan 2019

Breast Ultrasound CME Course with Tom Stavros, San Antonio 2019
Friday, 18 Jan 2019

Maternal-Fetal Imaging CME Course Advances in OB-GYN Ultrasound 2019
Friday, 18 Jan 2019

Latest News

Horses for Sale: The way to Select the proper Horse
Thursday, 17 Jan 2019

Online Betting
Thursday, 17 Jan 2019

Mechanical Ventilators Market is Anticipated to Reach US$ 2,937.3 Mn by 2026
Thursday, 17 Jan 2019

Global Pressure Relief Valve (PRV) Market By Application - Oil & Gas, Chemical Processing Industry
Thursday, 17 Jan 2019

Major Players In Global Electric Overhead Travelling (EOT) Crane Market - Harrington Hoists
Thursday, 17 Jan 2019

Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Thursday, 17 January 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Consumer Technology
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
News & Media
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!

Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.

  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.

  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Property Deal Network Leeds - Property Investor Meet up
  • 11th Annual ICJR Winter Hip and Knee Course, Vail 2019
  • ICRS Summit, San Diego, 2019 - Bio/Orthopaedics in Sport Medicine
  • Palo Alto Networks: GO FAST, STAY SECURE - Security for Public Clouds
  • 9th Annual Orthopaedic Trauma and Fracture Care: Pushing the Envelope

  • Latest Jobs
    Sorry, there are currently no entries posted here.